Type of outcome | Study entry | Baseline | 3Â months | 6Â months | 12Â months |
---|---|---|---|---|---|
Patient characteristics | Checking inclusion & exclusion criteria | x | Â | Â | Â |
Severity of urinary incontinence (ICIQ-UI SF) | Â | x | x | x | x |
Health-related quality of life (EQ-5D-5Â L) | Â | x | x | x | x |
Urogenital distress (UDI-6) | Â | x | x | x | x |
Improvement of UI (PGI-I) | Â | Â | x | x | x |
Depressive symptoms (CES-D) | Â | x | x | x | x |
use of absorbent products (in accordance with the recommended criteria in guidelines) (yes/no) | Â | x | x | x | x |
Costs (retrospective) | Â | Â | Â | Â | Â |
 questions based on TICP (past period) |  |  | x | x | x |
 pharmacist data (past 12 months) |  |  |  |  | x |